Dr David Landau is an expert oncologist based in London. He has a special interest in lung cancer, thymoma, mesothelioma, metastatic solid tumours and stereotactic radiotherapy and practises at a number of prominent medical institutions in the capital including LOC, which he is one of the founders of, and Guy's and St Thomas', his NHS base. He is a trained specialist in both stereotactic radiotherapy, using conventional linacs, and the CyberKnife system. Outside of his clinic he serves as senior lecturer at King's College London and is active in national cancer research. He has authored a number of peer-reviewed publications and given over 30 presentations at major conferences around the world.